2μm激光治疗前列腺增生症4年随访  

The RevoLix 2 micron continuous wave laser vaporesection for the treatment of benign prostatic hyperplasia： 4 years following-up outcome

作　　者：司捷旻[1] 谷宝军[1] 俞建军[1] 徐月敏[1] 

机构地区：[1]上海交通大学附属第六人民医院泌尿外科,上海200233

出　　处：《中国男科学杂志》2013年第7期42-44,共3页Chinese Journal of Andrology

摘　　要：目的探讨2μm激光治疗前列腺增生的长期疗效及并发症。方法2007年11月至2008年10月，采用2μm激光治疗良性前列腺增生116例，随访4年。结果患者平均年龄（72．4±3．6）岁，均安全度过围手术期。随访4年，平均国际前列腺症状评分（IPSS）（7．8±4．2）分，平均生活质量评分（QoL）（1．6±0．9）分，平均Qmax（19．6±7．9）ml／s，平均残余尿（22．4±12．8）ml。前列腺增生致再手术6．4％，膀胱颈部梗阻2．7％，尿道狭窄1．8％。结论21μm激光治疗前列腺增生是安全、有效的微创手术方法，长期疗效满意，长期并发症与经尿道前列腺电切术（TURP）相似。Objective To evaluate the long-term efficacy and the complication ocurrence rate of 2 μ m continuous- wave laser in the treatment of patients with benign prostatic hyperplasia（BPH）. Methods Total of 116 BPH patients underwent 2 μm continuous-wave laser prostatectomy between November 2007 and October 2008 and received 4 years following-up. IPSS, QOL, uroflowmetry, residual urine volume and complications of patients were measuted. Results Mean age of patients was （72.4±3.6）yr and mean preoperative prostate volume was （66.71±26.1）ml. After 4 yr, mean IPSS of patientswas （7.8±4.2）, the QoL score （1.6±0.9）, the Qmax （19.6±7.9）ml/s, and the Vres （22.4±12.8）ml. The retreatment rate was 6.4%. Urethral and bladder neck strictures occurred in 2.7% and 1.8% of the patients, respectively. Conclusion The RevoLix 2- la m continuous wave laser vaporesection is safe and effective in the treatment of patients with BPH, and its late complication occurrence rate is equal to that of transurethral electroresection of the prostate.

关 键 词：前列腺增生 激光 

分 类 号：R697.32[医药卫生—泌尿科学]